- Visibility 259 Views
- Downloads 223 Downloads
- Permissions
- DOI 10.18231/j.ijced.67329.1758875654
-
CrossMark
- Citation
A comparative study on efficacy of oral ultramicrosized griseofulvin and oral itraconazole on dermatophytic infection of skin
Introduction: Dermatophytosis is a common superficial fungal infection affecting keratinized tissues, with significant health and cosmetic impacts. Though itraconazole is widely used due to its broad-spectrum antifungal efficacy, its higher cost and adverse effects necessitate exploration of alternatives like ultramicrosized griseofulvin. This study aimed to compare the clinical efficacy, safety, and cost-effectiveness of oral itraconazole and oral ultramicrosized griseofulvin in the treatment of tinea corporis and tinea cruris.
Materials and Methods: A randomized controlled trial was conducted over 24 months at Eraβs Lucknow Medical College & Hospital. A total of 243 patients with KOH-confirmed tinea corporis or tinea cruris were randomly allocated into two groups: Group A (n=121) received oral itraconazole 100 mg twice daily, and Group B (n=122) received oral ultramicrosized griseofulvin 500 mg twice daily for six weeks. Clinical, mycological, and symptomatic evaluations were performed at baseline and at 2, 4, 6, and 8 weeks. p-values <0.05 considered statistically significant.
Results: Both groups were comparable in baseline demographic and clinical characteristics. Among the 88 patients receiving itraconazole and 83 receiving ultramicrosized griseofulvin, recurrence rates were comparable. At 8 weeks, scaling resolution was significantly higher with Itraconazole (97.0% vs 76.9%), while erythema and pruritus showed similar improvement across groups. Recurrence rates and KOH negativity were comparable between groups. No adverse events necessitating treatment withdrawal were reported in either group.
Conclusion: Ultramicrosized griseofulvin is a safe, cost-effective, and clinically effective alternative to itraconazole for treating dermatophytosis, particularly in low-resource settings.
How to Cite This Article
Vancouver
Singh A, Saxena K, Kalawat R, . K, Bansal B, Srivastava H, Khatri N. A comparative study on efficacy of oral ultramicrosized griseofulvin and oral itraconazole on dermatophytic infection of skin [Internet]. IP Indian J Clin Exp Dermatol. 2025 [cited 2025 Nov 08];11(3):372-378. Available from: https://doi.org/10.18231/j.ijced.67329.1758875654
APA
Singh, A., Saxena, K., Kalawat, R., ., K., Bansal, B., Srivastava, H., Khatri, N. (2025). A comparative study on efficacy of oral ultramicrosized griseofulvin and oral itraconazole on dermatophytic infection of skin. IP Indian J Clin Exp Dermatol, 11(3), 372-378. https://doi.org/10.18231/j.ijced.67329.1758875654
MLA
Singh, Amarjeet, Saxena, Kshitij, Kalawat, Riya, ., Ketki, Bansal, Bhavika, Srivastava, Hansa, Khatri, Nidhi. "A comparative study on efficacy of oral ultramicrosized griseofulvin and oral itraconazole on dermatophytic infection of skin." IP Indian J Clin Exp Dermatol, vol. 11, no. 3, 2025, pp. 372-378. https://doi.org/10.18231/j.ijced.67329.1758875654
Chicago
Singh, A., Saxena, K., Kalawat, R., ., K., Bansal, B., Srivastava, H., Khatri, N.. "A comparative study on efficacy of oral ultramicrosized griseofulvin and oral itraconazole on dermatophytic infection of skin." IP Indian J Clin Exp Dermatol 11, no. 3 (2025): 372-378. https://doi.org/10.18231/j.ijced.67329.1758875654